The role of glia in α-synucleinopathies.

Molecular neurobiology

Volumn 47, Issue 2, 2013, Pages 575-586

  Fellner, Lisa ^a   Stefanova, Nadia ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ANIMAL; GLIA; HUMAN; METABOLISM; NERVE CELL; NEURODEGENERATIVE DISEASES; OLIGODENDROGLIA; PATHOLOGY; PHYSIOLOGY;

ALPHA-SYNUCLEIN; ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS; OLIGODENDROGLIA;

EID: 84891836634     PISSN: None     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8340-3     Document Type: Review

References (164)

1. 1. B Greten-Harrison M Polydoro M Morimoto-Tomita L Diao AM Williams EH Nie S Makani N Tian PE Castillo VL Buchman SS Chandra 2010 Alphabetagamma-synuclein triple knockout mice reveal age-dependent neuronal dysfunction Proc Natl Acad Sci U S A 107 45 19573 19578 20974939 1:CAS:528:DC%2BC3cXhsVGlur%2FK 10.1073/pnas.1005005107 Greten-Harrison B, Polydoro M, Morimoto-Tomita M, Diao L, Williams AM, Nie EH, Makani S, Tian N, Castillo PE, Buchman VL, Chandra SS (2010) Alphabetagamma-synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc Natl Acad Sci U S A 107(45):19573–19578
2. 2. S Chandra G Gallardo R Fernandez-Chacon OM Schluter TC Sudhof 2005 Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration Cell 123 3 383 396 16269331 1:CAS:528:DC%2BD2MXht1altLnN 10.1016/j.cell.2005.09.028 Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123(3):383–396
3. 3. K Beyer A Ariza 2007 Protein aggregation mechanisms in synucleinopathies: commonalities and differences J Neuropathol Exp Neurol 66 11 965 974 10.1097/nen.0b013e3181587d64 17984679 1:CAS:528:DC%2BD2sXhtl2ntLzI 10.1097/nen.0b013e3181587d64 Beyer K, Ariza A (2007) Protein aggregation mechanisms in synucleinopathies: commonalities and differences. J Neuropathol Exp Neurol 66(11):965–974. doi: 10.1097/nen.0b013e3181587d64
4. 4. MG Spillantini RA Crowther R Jakes NJ Cairns PL Lantos M Goedert 1998 Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies Neurosci Lett 251 3 205 208 9726379 1:STN:280:DyaK1czpt12rsg%3D%3D 10.1016/S0304-3940(98)00504-7 Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett 251(3):205–208
5. 5. H Braak M Sastre K Tredici Del 2007 Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease Acta Neuropathol 114 3 231 241 10.1007/s00401-007-0244-3 17576580 1:CAS:528:DC%2BD2sXosFKrsLc%3D 10.1007/s00401-007-0244-3 Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease. Acta Neuropathol 114(3):231–241. doi: 10.1007/s00401-007-0244-3
6. 6. K Wakabayashi S Hayashi M Yoshimoto H Kudo H Takahashi 2000 NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains Acta Neuropathol 99 1 14 20 10651022 1:CAS:528:DyaK1MXnslWru74%3D 10.1007/PL00007400 Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains. Acta Neuropathol 99(1):14–20
7. 7. MH Polymeropoulos C Lavedan E Leroy SE Ide A Dehejia A Dutra B Pike H Root J Rubenstein R Boyer ES Stenroos S Chandrasekharappa A Athanassiadou T Papapetropoulos WG Johnson AM Lazzarini RC Duvoisin G Iorio Di LI Golbe RL Nussbaum 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease Science 276 5321 2045 2047 9197268 1:CAS:528:DyaK2sXkt1altr4%3D 10.1126/science.276.5321.2045 Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276(5321):2045–2047
8. 8. JJ Zarranz J Alegre JC Gomez-Esteban E Lezcano R Ros I Ampuero L Vidal J Hoenicka O Rodriguez B Atares V Llorens E Gomez Tortosa T Ser del DG Munoz JG Yebenes de 2004 The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann Neurol 55 2 164 173 10.1002/ana.10795 14755719 1:CAS:528:DC%2BD2cXhs1Sgtb0%3D 10.1002/ana.10795 Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164–173. doi: 10.1002/ana.10795
9. 9. K Nishioka S Hayashi MJ Farrer AB Singleton H Yoshino H Imai T Kitami K Sato R Kuroda H Tomiyama K Mizoguchi M Murata T Toda I Imoto J Inazawa Y Mizuno N Hattori 2006 Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson’s disease Ann Neurol 59 2 298 309 10.1002/ana.20753 16358335 1:CAS:528:DC%2BD28XhvVSksrc%3D 10.1002/ana.20753 Nishioka K, Hayashi S, Farrer MJ, Singleton AB, Yoshino H, Imai H, Kitami T, Sato K, Kuroda R, Tomiyama H, Mizoguchi K, Murata M, Toda T, Imoto I, Inazawa J, Mizuno Y, Hattori N (2006) Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson’s disease. Ann Neurol 59(2):298–309. doi: 10.1002/ana.20753
10. 10. MJ Devine M Ryten P Vodicka AJ Thomson T Burdon H Houlden F Cavaleri M Nagano NJ Drummond JW Taanman AH Schapira K Gwinn J Hardy PA Lewis T Kunath 2011 Parkinson’s disease induced pluripotent stem cells with triplication of the alpha-synuclein locus Nat Commun 2 440 10.1038/ncomms1453 21863007 10.1038/ncomms1453 1:CAS:528:DC%2BC3MXht1Gjtr%2FN Devine MJ, Ryten M, Vodicka P, Thomson AJ, Burdon T, Houlden H, Cavaleri F, Nagano M, Drummond NJ, Taanman JW, Schapira AH, Gwinn K, Hardy J, Lewis PA, Kunath T (2011) Parkinson’s disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat Commun 2:440. doi: 10.1038/ncomms1453
11. 11. AB Singleton M Farrer J Johnson A Singleton S Hague J Kachergus M Hulihan T Peuralinna A Dutra R Nussbaum S Lincoln A Crawley M Hanson D Maraganore C Adler MR Cookson M Muenter M Baptista D Miller J Blancato J Hardy K Gwinn-Hardy 2003 alpha-Synuclein locus triplication causes Parkinson’s disease Science 302 5646 841 10.1126/science.1090278 14593171 1:CAS:528:DC%2BD3sXoslehsbc%3D 10.1126/science.1090278 Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) alpha-Synuclein locus triplication causes Parkinson’s disease. Science 302(5646):841. doi: 10.1126/science.1090278
12. 12. TL Edwards WK Scott C Almonte A Burt EH Powell GW Beecham L Wang S Zuchner I Konidari G Wang C Singer F Nahab B Scott JM Stajich M Pericak-Vance J Haines JM Vance ER Martin 2010 Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease Ann Hum Genet 74 2 97 109 20070850 1:CAS:528:DC%2BC3cXksVKgt7s%3D 10.1111/j.1469-1809.2009.00560.x Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Zuchner S, Konidari I, Wang G, Singer C, Nahab F, Scott B, Stajich JM, Pericak-Vance M, Haines J, Vance JM, Martin ER (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74(2):97–109
13. 13. SW Scholz H Houlden C Schulte M Sharma A Li D Berg A Melchers R Paudel JR Gibbs J Simon-Sanchez C Paisan-Ruiz J Bras J Ding H Chen BJ Traynor S Arepalli RR Zonozi T Revesz J Holton N Wood A Lees W Oertel U Wullner S Goldwurm MT Pellecchia T Illig O Riess HH Fernandez RL Rodriguez MS Okun W Poewe GK Wenning JA Hardy AB Singleton F Sorbo Del S Schneider KP Bhatia T Gasser 2009 SNCA variants are associated with increased risk for multiple system atrophy Ann Neurol 65 5 610 614 10.1002/ana.21685 19475667 1:CAS:528:DC%2BD1MXnvFahsb8%3D 10.1002/ana.21685 Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wullner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Del Sorbo F, Schneider S, Bhatia KP, Gasser T (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65(5):610–614. doi: 10.1002/ana.21685
14. 14. JP Anderson DE Walker JM Goldstein R Laat de K Banducci RJ Caccavello R Barbour J Huang K Kling M Lee L Diep PS Keim X Shen T Chataway MG Schlossmacher P Seubert D Schenk S Sinha WP Gai TJ Chilcote 2006 Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease J Biol Chem 281 40 29739 29752 16847063 1:CAS:528:DC%2BD28XhtVahsb%2FI 10.1074/jbc.M600933200 Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chataway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, Chilcote TJ (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281(40):29739–29752
15. 15. BI Giasson JE Duda IV Murray Q Chen JM Souza HI Hurtig H Ischiropoulos JQ Trojanowski VM Lee 2000 Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 5493 985 989 11062131 1:CAS:528:DC%2BD3cXnvVWkurY%3D 10.1126/science.290.5493.985 Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290(5493):985–989
16. 16. GK Tofaris A Razzaq B Ghetti KS Lilley MG Spillantini 2003 Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function J Biol Chem 278 45 44405 44411 10.1074/jbc.M308041200 12923179 1:CAS:528:DC%2BD3sXoslWmur8%3D 10.1074/jbc.M308041200 Tofaris GK, Razzaq A, Ghetti B, Lilley KS, Spillantini MG (2003) Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem 278(45):44405–44411. doi: 10.1074/jbc.M308041200
17. 17. AR Winslow CW Chen S Corrochano A Acevedo-Arozena DE Gordon AA Peden M Lichtenberg FM Menzies B Ravikumar S Imarisio S Brown CJ O’Kane DC Rubinsztein 2010 alpha-Synuclein impairs macroautophagy: implications for Parkinson’s disease J Cell Biol 190 6 1023 1037 20855506 1:CAS:528:DC%2BC3cXht1ahsbjK 10.1083/jcb.201003122 Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, Lichtenberg M, Menzies FM, Ravikumar B, Imarisio S, Brown S, O’Kane CJ, Rubinsztein DC (2010) alpha-Synuclein impairs macroautophagy: implications for Parkinson’s disease. J Cell Biol 190(6):1023–1037
18. 18. M Xilouri L Stefanis 2011 Autophagic pathways in Parkinson disease and related disorders Expert Rev Mol Med 13 e8 21418705 10.1017/S1462399411001803 1:CAS:528:DC%2BC3MXksVKjur0%3D Xilouri M, Stefanis L (2011) Autophagic pathways in Parkinson disease and related disorders. Expert Rev Mol Med 13:e8
19. 19. T Ozawa D Paviour NP Quinn KA Josephs H Sangha L Kilford DG Healy NW Wood AJ Lees JL Holton T Revesz 2004 The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations Brain 127 Pt 12 2657 2671 15509623 10.1093/brain/awh303 Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, Healy DG, Wood NW, Lees AJ, Holton JL, Revesz T (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127(Pt 12):2657–2671
20. 20. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–5
21. 21. P Desplats HJ Lee EJ Bae C Patrick E Rockenstein L Crews B Spencer E Masliah SJ Lee 2009 Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein Proc Natl Acad Sci U S A 106 31 13010 13015 19651612 1:CAS:528:DC%2BD1MXhtVKru7%2FM 10.1073/pnas.0903691106 Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 106(31):13010–13015
22. 22. C Hansen E Angot AL Bergstrom JA Steiner L Pieri G Paul TF Outeiro R Melki P Kallunki K Fog JY Li P Brundin 2011 alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells J Clin Invest 121 2 715 725 10.1172/JCI43366 21245577 1:CAS:528:DC%2BC3MXhsl2qsro%3D 10.1172/JCI43366 Hansen C, Angot E, Bergstrom AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R, Kallunki P, Fog K, Li JY, Brundin P (2011) alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 121(2):715–725. doi: 10.1172/JCI43366
23. 23. HJ Lee JE Suk C Patrick EJ Bae JH Cho S Rho D Hwang E Masliah SJ Lee 2010 Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies J Biol Chem 285 12 9262 9272 20071342 1:CAS:528:DC%2BC3cXjtFShtLk%3D 10.1074/jbc.M109.081125 Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, Hwang D, Masliah E, Lee SJ (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285(12):9262–9272
24. 24. DN Hauser MR Cookson 2011 Astrocytes in Parkinson’s disease and DJ-1 J Neurochem 117 3 357 358 10.1111/j.1471-4159.2011.07217.x 21413989 1:CAS:528:DC%2BC3MXls1Oju7o%3D 10.1111/j.1471-4159.2011.07217.x Hauser DN, Cookson MR (2011) Astrocytes in Parkinson’s disease and DJ-1. J Neurochem 117(3):357–358. doi: 10.1111/j.1471-4159.2011.07217.x
25. 25. H Webster KE Astrom 2009 Gliogenesis: historical perspectives, 1839–1985 Adv Anat Embryol Cell Biol 202 1 109 19230601 10.1007/978-3-540-87534-5_1 Webster H, Astrom KE (2009) Gliogenesis: historical perspectives, 1839–1985. Adv Anat Embryol Cell Biol 202:1–109
26. 26. L Fellner KA Jellinger GK Wenning N Stefanova 2011 Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts Acta Neuropathol 121 6 675 693 10.1007/s00401-011-0833-z 21562886 1:CAS:528:DC%2BC3MXmsVWrtrY%3D 10.1007/s00401-011-0833-z Fellner L, Jellinger KA, Wenning GK, Stefanova N (2011) Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts. Acta Neuropathol 121(6):675–693. doi: 10.1007/s00401-011-0833-z
27. 27. A Gerhard RB Banati GB Goerres A Cagnin R Myers RN Gunn F Turkheimer CD Good CJ Mathias N Quinn J Schwarz DJ Brooks 2003 [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy Neurology 61 5 686 689 12963764 1:STN:280:DC%2BD3svitlagtg%3D%3D 10.1212/01.WNL.0000078192.95645.E6 Gerhard A, Banati RB, Goerres GB, Cagnin A, Myers R, Gunn RN, Turkheimer F, Good CD, Mathias CJ, Quinn N, Schwarz J, Brooks DJ (2003) [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61(5):686–689
28. 28. A Gerhard N Pavese G Hotton F Turkheimer M Es A Hammers K Eggert W Oertel RB Banati DJ Brooks 2006 In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson’s disease Neurobiol Dis 21 2 404 412 16182554 1:CAS:528:DC%2BD28XmsVGmsg%3D%3D 10.1016/j.nbd.2005.08.002 Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, Eggert K, Oertel W, Banati RB, Brooks DJ (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson’s disease. Neurobiol Dis 21(2):404–412
29. 29. GM Halliday CH Stevens 2011 Glia: initiators and progressors of pathology in Parkinson’s disease Mov Disord 26 1 6 17 10.1002/mds.23455 21322014 10.1002/mds.23455 Halliday GM, Stevens CH (2011) Glia: initiators and progressors of pathology in Parkinson’s disease. Mov Disord 26(1):6–17. doi: 10.1002/mds.23455
30. 30. A Nimmerjahn F Kirchhoff F Helmchen 2005 Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo Science 308 5726 1314 1318 15831717 1:CAS:528:DC%2BD2MXks1Ciuro%3D 10.1126/science.1110647 Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308(5726):1314–1318
31. 31. U Wilhelmsson EA Bushong DL Price BL Smarr V Phung M Terada MH Ellisman M Pekny 2006 Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury Proc Natl Acad Sci U S A 103 46 17513 17518 17090684 1:CAS:528:DC%2BD28Xht1Ojs77E 10.1073/pnas.0602841103 Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M, Ellisman MH, Pekny M (2006) Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A 103(46):17513–17518
32. 32. P Rio-Hortega del 1932 Microglia W Penfield Cytology and cellular pathology of the nervous system Hoeber, PB New York 483 534 del Rio-Hortega P (1932) Microglia. In: Penfield W (ed) Cytology and cellular pathology of the nervous system. Hoeber, PB, New York, pp 483–534
33. 33. CM Liberto PJ Albrecht LM Herx VW Yong SW Levison 2004 Pro-regenerative properties of cytokine-activated astrocytes J Neurochem 89 5 1092 1100 10.1111/j.1471-4159.2004.02420.x 15147501 1:CAS:528:DC%2BD2cXkvFOktLc%3D 10.1111/j.1471-4159.2004.02420.x Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW (2004) Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 89(5):1092–1100. doi: 10.1111/j.1471-4159.2004.02420.x
34. 34. D Rossum van UK Hanisch 2004 Microglia Metab Brain Dis 19 3–4 393 411 15554430 10.1023/B:MEBR.0000043984.73063.d8 van Rossum D, Hanisch UK (2004) Microglia. Metab Brain Dis 19(3–4):393–411
35. 35. JM Dean X Wang AM Kaindl P Gressens B Fleiss H Hagberg C Mallard 2010 Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro Brain Behav Immun 24 5 776 783 19903519 1:CAS:528:DC%2BC3cXnsVamtbc%3D 10.1016/j.bbi.2009.10.018 Dean JM, Wang X, Kaindl AM, Gressens P, Fleiss B, Hagberg H, Mallard C (2010) Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro. Brain Behav Immun 24(5):776–783
36. 36. M Deshpande J Zheng K Borgmann R Persidsky L Wu C Schellpeper A Ghorpade 2005 Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia Neurotox Res 7 3 183 192 15897153 1:CAS:528:DC%2BD28XhtFKqsbbF 10.1007/BF03036448 Deshpande M, Zheng J, Borgmann K, Persidsky R, Wu L, Schellpeper C, Ghorpade A (2005) Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia. Neurotox Res 7(3):183–192
37. 37. T Mizuno R Kuno A Nitta T Nabeshima G Zhang J Kawanokuchi J Wang S Jin H Takeuchi A Suzumura 2005 Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes Brain Res 1066 1–2 78 85 16325157 1:CAS:528:DC%2BD2MXhtlWqurzM 10.1016/j.brainres.2005.10.050 Mizuno T, Kuno R, Nitta A, Nabeshima T, Zhang G, Kawanokuchi J, Wang J, Jin S, Takeuchi H, Suzumura A (2005) Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes. Brain Res 1066(1–2):78–85
38. 38. H Neumann R Schweigreiter T Yamashita K Rosenkranz H Wekerle YA Barde 2002 Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism J Neurosci 22 3 854 862 11826115 1:CAS:528:DC%2BD38XhtFygu7Y%3D Neumann H, Schweigreiter R, Yamashita T, Rosenkranz K, Wekerle H, Barde YA (2002) Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J Neurosci 22(3):854–862
39. 39. L Qian PM Flood 2008 Microglial cells and Parkinson’s disease Immunol Res 41 3 155 164 10.1007/s12026-008-8018-0 18512160 1:CAS:528:DC%2BD1cXht1Kqtb3E 10.1007/s12026-008-8018-0 Qian L, Flood PM (2008) Microglial cells and Parkinson’s disease. Immunol Res 41(3):155–164. doi: 10.1007/s12026-008-8018-0
40. 40. L Qian PM Flood JS Hong 2010 Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy J Neural Transm 117 8 971 979 10.1007/s00702-010-0428-1 20571837 1:CAS:528:DC%2BC3cXpvVSrsLs%3D 10.1007/s00702-010-0428-1 Qian L, Flood PM, Hong JS (2010) Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy. J Neural Transm 117(8):971–979. doi: 10.1007/s00702-010-0428-1
41. 41. A Jurewicz M Matysiak K Tybor L Kilianek CS Raine K Selmaj 2005 Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor Brain 128 Pt 11 2675 2688 16219674 10.1093/brain/awh627 Jurewicz A, Matysiak M, Tybor K, Kilianek L, Raine CS, Selmaj K (2005) Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain 128(Pt 11):2675–2688
42. 42. SK Thorburne BH Juurlink 1996 Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress J Neurochem 67 3 1014 1022 8752107 1:CAS:528:DyaK28XltlKkt7k%3D 10.1046/j.1471-4159.1996.67031014.x Thorburne SK, Juurlink BH (1996) Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 67(3):1014–1022
43. 43. ER Dorsey R Constantinescu JP Thompson KM Biglan RG Holloway K Kieburtz FJ Marshall BM Ravina G Schifitto A Siderowf CM Tanner 2007 Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 Neurology 68 5 384 386 17082464 1:STN:280:DC%2BD2s%2FlsFOmug%3D%3D 10.1212/01.wnl.0000247740.47667.03 Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384–386
44. 44. S Fahn 2003 Description of Parkinson’s disease as a clinical syndrome Ann N Y Acad Sci 991 1 14 12846969 1:CAS:528:DC%2BD3sXmtVCkur4%3D 10.1111/j.1749-6632.2003.tb07458.x Fahn S (2003) Description of Parkinson’s disease as a clinical syndrome. Ann N Y Acad Sci 991:1–14
45. 45. IG McKeith DJ Burn CG Ballard D Collerton E Jaros CM Morris A McLaren EK Perry R Perry MA Piggott JT O’Brien 2003 Dementia with Lewy bodies Semin Clin Neuropsychiatry 8 1 46 57 10.1053/scnp. 2003.50006 12567332 10.1053/scnp.2003.50006 McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O’Brien JT (2003) Dementia with Lewy bodies. Semin Clin Neuropsychiatry 8(1):46–57. doi: 10.1053/scnp.2003.50006
46. 46. KA Jellinger 2003 Neuropathological spectrum of synucleinopathies Mov Disord 18 Suppl 6 S2 12 14502650 10.1002/mds.10557 Jellinger KA (2003) Neuropathological spectrum of synucleinopathies. Mov Disord 18(Suppl 6):S2–12
47. 47. KA Jellinger 2007 Lewy body disorders MBH Youdim P Riederer SA Mandel L Battistin A Lajtha Degenerative diseases of the nervous system Springer Science New York 267 343 Jellinger KA (2007) Lewy body disorders. In: Youdim MBH, Riederer P, Mandel SA, Battistin L, Lajtha A (eds) Degenerative diseases of the nervous system. Springer Science, New York, pp 267–343
48. 48. WJ Schulz-Schaeffer 2010 The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia Acta Neuropathol 120 2 131 143 10.1007/s00401-010-0711-0 20563819 1:CAS:528:DC%2BC3cXotVKnsbw%3D 10.1007/s00401-010-0711-0 Schulz-Schaeffer WJ (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia. Acta Neuropathol 120(2):131–143. doi: 10.1007/s00401-010-0711-0
49. 49. M Baba S Nakajo PH Tu T Tomita K Nakaya VM Lee JQ Trojanowski T Iwatsubo 1998 Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies Am J Pathol 152 4 879 884 9546347 1:CAS:528:DyaK1cXivVKgsbc%3D Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am J Pathol 152(4):879–884
50. 50. LS Forno 1996 Neuropathology of Parkinson’s disease J Neuropathol Exp Neurol 55 3 259 272 8786384 1:STN:280:DyaK283gslyhsw%3D%3D 10.1097/00005072-199603000-00001 Forno LS (1996) Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol 55(3):259–272
51. 51. MM Tompkins WD Hill 1997 Contribution of somal Lewy bodies to neuronal death Brain Res 775 1–2 24 29 9439824 1:CAS:528:DyaK2sXnvVSnsLs%3D 10.1016/S0006-8993(97)00874-3 Tompkins MM, Hill WD (1997) Contribution of somal Lewy bodies to neuronal death. Brain Res 775(1–2):24–29
52. 52. IR Mackenzie 2000 Activated microglia in dementia with Lewy bodies Neurology 55 1 132 134 10891923 1:STN:280:DC%2BD3czovVOgtA%3D%3D 10.1212/WNL.55.1.132 Mackenzie IR (2000) Activated microglia in dementia with Lewy bodies. Neurology 55(1):132–134
53. 53. CF Orr DB Rowe Y Mizuno H Mori GM Halliday 2005 A possible role for humoral immunity in the pathogenesis of Parkinson’s disease Brain 128 Pt 11 2665 2674 16219675 10.1093/brain/awh625 Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM (2005) A possible role for humoral immunity in the pathogenesis of Parkinson’s disease. Brain 128(Pt 11):2665–2674
54. 54. S Hashioka A Klegeris C Schwab PL McGeer 2009 Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells Neurobiol Aging 30 12 1924 1935 18375019 1:CAS:528:DC%2BD1MXht1yjtb%2FK 10.1016/j.neurobiolaging.2008.02.019 Hashioka S, Klegeris A, Schwab C, McGeer PL (2009) Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiol Aging 30(12):1924–1935
55. 55. C Knott G Stern A Kingsbury AA Welcher GP Wilkin 2002 Elevated glial brain-derived neurotrophic factor in Parkinson’s diseased nigra Parkinsonism Relat Disord 8 5 329 341 15177062 1:STN:280:DC%2BD2c3nvFemsw%3D%3D 10.1016/S1353-8020(02)00008-1 Knott C, Stern G, Kingsbury A, Welcher AA, Wilkin GP (2002) Elevated glial brain-derived neurotrophic factor in Parkinson’s diseased nigra. Parkinsonism Relat Disord 8(5):329–341
56. 56. B Mirza H Hadberg P Thomsen T Moos 2000 The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson’s disease Neuroscience 95 2 425 432 10658622 1:CAS:528:DyaK1MXnslGmu7o%3D 10.1016/S0306-4522(99)00455-8 Mirza B, Hadberg H, Thomsen P, Moos T (2000) The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson’s disease. Neuroscience 95(2):425–432
57. 57. M Vila V Jackson-Lewis C Guegan DC Wu P Teismann DK Choi K Tieu S Przedborski 2001 The role of glial cells in Parkinson’s disease Curr Opin Neurol 14 4 483 489 11470965 1:STN:280:DC%2BD3MvitFSjsA%3D%3D 10.1097/00019052-200108000-00009 Vila M, Jackson-Lewis V, Guegan C, Wu DC, Teismann P, Choi DK, Tieu K, Przedborski S (2001) The role of glial cells in Parkinson’s disease. Curr Opin Neurol 14(4):483–489
58. 58. EC Hirsch S Hunot A Hartmann 2005 Neuroinflammatory processes in Parkinson’s disease Parkinsonism Relat Disord 11 Suppl 1 S9 S15 15885630 10.1016/j.parkreldis.2004.10.013 Hirsch EC, Hunot S, Hartmann A (2005) Neuroinflammatory processes in Parkinson’s disease. Parkinsonism Relat Disord 11(Suppl 1):S9–S15
59. 59. XL Gu CX Long L Sun C Xie X Lin H Cai 2010 Astrocytic expression of Parkinson’s disease-related A53T alpha-synuclein causes neurodegeneration in mice Mol Brain 3 12 20409326 10.1186/1756-6606-3-12 1:CAS:528:DC%2BC3cXls1Kjsb8%3D Gu XL, Long CX, Sun L, Xie C, Lin X, Cai H (2010) Astrocytic expression of Parkinson’s disease-related A53T alpha-synuclein causes neurodegeneration in mice. Mol Brain 3:12
60. 60. S Hashioka A Klegeris C Schwab S Yu PL McGeer 2010 Differential expression of interferon-gamma receptor on human glial cells in vivo and in vitro J Neuroimmunol 225 1–2 91 99 20554027 1:CAS:528:DC%2BC3cXhtVKhu73O 10.1016/j.jneuroim.2010.04.023 Hashioka S, Klegeris A, Schwab C, Yu S, McGeer PL (2010) Differential expression of interferon-gamma receptor on human glial cells in vivo and in vitro. J Neuroimmunol 225(1–2):91–99
61. 61. DK Choi S Pennathur C Perier K Tieu P Teismann DC Wu V Jackson-Lewis M Vila JP Vonsattel JW Heinecke S Przedborski 2005 Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson’s disease in mice J Neurosci 25 28 6594 6600 16014720 1:CAS:528:DC%2BD2MXmslCltLc%3D 10.1523/JNEUROSCI.0970-05.2005 Choi DK, Pennathur S, Perier C, Tieu K, Teismann P, Wu DC, Jackson-Lewis V, Vila M, Vonsattel JP, Heinecke JW, Przedborski S (2005) Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson’s disease in mice. J Neurosci 25(28):6594–6600
62. 62. P Damier EC Hirsch P Zhang Y Agid F Javoy-Agid 1993 Glutathione peroxidase, glial cells and Parkinson’s disease Neuroscience 52 1 1 6 8433802 1:STN:280:DyaK3s7msFWktg%3D%3D 10.1016/0306-4522(93)90175-F Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F (1993) Glutathione peroxidase, glial cells and Parkinson’s disease. Neuroscience 52(1):1–6
63. 63. RB Mythri C Venkateshappa G Harish A Mahadevan UB Muthane TC Yasha MM Srinivas Bharath SK Shankar 2011 Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson’s disease brains Neurochem Res 36 8 1452 1463 10.1007/s11064-011-0471-9 21484266 1:CAS:528:DC%2BC3MXksFWntbg%3D 10.1007/s11064-011-0471-9 Mythri RB, Venkateshappa C, Harish G, Mahadevan A, Muthane UB, Yasha TC, Srinivas Bharath MM, Shankar SK (2011) Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson’s disease brains. Neurochem Res 36(8):1452–1463. doi: 10.1007/s11064-011-0471-9
64. 64. C Barcia CM Ros V Annese A Gomez F Ros-Bernal D Aguado-Yera ME Martinez-Pagan V Pablos de E Fernandez-Villalba MT Herrero 2011 IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson’s disease Cell Death Dis 2 e142 21472005 1:CAS:528:DC%2BC3MXot1yks7s%3D 10.1038/cddis.2011.17 Barcia C, Ros CM, Annese V, Gomez A, Ros-Bernal F, Aguado-Yera D, Martinez-Pagan ME, de Pablos V, Fernandez-Villalba E, Herrero MT (2011) IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson’s disease. Cell Death Dis 2:e142
65. 65. S Schmidt B Linnartz S Mendritzki T Sczepan M Lubbert CC Stichel H Lubbert 2011 Genetic mouse models for Parkinson’s disease display severe pathology in glial cell mitochondria Hum Mol Genet 20 6 1197 1211 21212098 1:CAS:528:DC%2BC3MXisFagtrw%3D 10.1093/hmg/ddq564 Schmidt S, Linnartz B, Mendritzki S, Sczepan T, Lubbert M, Stichel CC, Lubbert H (2011) Genetic mouse models for Parkinson’s disease display severe pathology in glial cell mitochondria. Hum Mol Genet 20(6):1197–1211
66. 66. MC Schiess JL Barnes TM Ellmore BJ Poindexter K Dinh RJ Bick 2010 CSF from Parkinson disease patients differentially affects cultured microglia and astrocytes BMC Neurosci 11 151 21114836 10.1186/1471-2202-11-S1-P151 Schiess MC, Barnes JL, Ellmore TM, Poindexter BJ, Dinh K, Bick RJ (2010) CSF from Parkinson disease patients differentially affects cultured microglia and astrocytes. BMC Neurosci 11:151
67. 67. A Klegeris BI Giasson H Zhang J Maguire S Pelech PL McGeer 2006 Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells FASEB J 20 12 2000 2008 17012252 1:CAS:528:DC%2BD28XhtVyhtbnJ 10.1096/fj.06-6183com Klegeris A, Giasson BI, Zhang H, Maguire J, Pelech S, McGeer PL (2006) Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. FASEB J 20(12):2000–2008
68. 68. A Saavedra G Baltazar P Santos CM Carvalho EP Duarte 2006 Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk Neurobiol Dis 23 3 533 542 16766196 1:CAS:528:DC%2BD28XotlWnsLk%3D 10.1016/j.nbd.2006.04.008 Saavedra A, Baltazar G, Santos P, Carvalho CM, Duarte EP (2006) Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk. Neurobiol Dis 23(3):533–542
69. 69. JK Sandhu M Gardaneh R Iwasiow P Lanthier S Gangaraju M Ribecco-Lutkiewicz R Tremblay K Kiuchi M Sikorska 2009 Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity Neurobiol Dis 33 3 405 414 19118631 1:CAS:528:DC%2BD1MXitVSjsbY%3D 10.1016/j.nbd.2008.11.016 Sandhu JK, Gardaneh M, Iwasiow R, Lanthier P, Gangaraju S, Ribecco-Lutkiewicz M, Tremblay R, Kiuchi K, Sikorska M (2009) Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity. Neurobiol Dis 33(3):405–414
70. 70. M Lee C Schwab S Yu E McGeer PL McGeer 2009 Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide Neurobiol Aging 30 10 1523 1534 19631409 1:CAS:528:DC%2BD1MXhtVKgsL7L 10.1016/j.neurobiolaging.2009.06.001 Lee M, Schwab C, Yu S, McGeer E, McGeer PL (2009) Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging 30(10):1523–1534
71. 71. PL McGeer S Itagaki BE Boyes EG McGeer 1988 Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains Neurology 38 8 1285 1291 3399080 1:STN:280:DyaL1c3ovVKkuw%3D%3D 10.1212/WNL.38.8.1285 McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38(8):1285–1291
72. 72. K Imamura N Hishikawa M Sawada T Nagatsu M Yoshida Y Hashizume 2003 Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson’s disease brains Acta Neuropathol 106 6 518 526 10.1007/s00401-003-0766-2 14513261 1:CAS:528:DC%2BD3sXos1Clsrs%3D 10.1007/s00401-003-0766-2 Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson’s disease brains. Acta Neuropathol 106(6):518–526. doi: 10.1007/s00401-003-0766-2
73. 73. K Imamura N Hishikawa K Ono H Suzuki M Sawada T Nagatsu M Yoshida Y Hashizume 2005 Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains Acta Neuropathol 109 2 141 150 10.1007/s00401-004-0919-y 15619128 1:CAS:528:DC%2BD2MXis1Oktbw%3D 10.1007/s00401-004-0919-y Imamura K, Hishikawa N, Ono K, Suzuki H, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2005) Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains. Acta Neuropathol 109(2):141–150. doi: 10.1007/s00401-004-0919-y
74. 74. Y Ouchi E Yoshikawa Y Sekine M Futatsubashi T Kanno T Ogusu T Torizuka 2005 Microglial activation and dopamine terminal loss in early Parkinson’s disease Ann Neurol 57 2 168 175 10.1002/ana.20338 15668962 1:CAS:528:DC%2BD2MXhs1Cisb8%3D 10.1002/ana.20338 Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson’s disease. Ann Neurol 57(2):168–175. doi: 10.1002/ana.20338
75. 75. X Su HJ Federoff KA Maguire-Zeiss 2009 Mutant alpha-synuclein overexpression mediates early proinflammatory activity Neurotox Res 16 3 238 254 10.1007/s12640-009-9053-x 19526281 1:CAS:528:DC%2BD1MXhtFOkt7nF 10.1007/s12640-009-9053-x Su X, Federoff HJ, Maguire-Zeiss KA (2009) Mutant alpha-synuclein overexpression mediates early proinflammatory activity. Neurotox Res 16(3):238–254. doi: 10.1007/s12640-009-9053-x
76. 76. A Klegeris S Pelech BI Giasson J Maguire H Zhang EG McGeer PL McGeer 2008 Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia Neurobiol Aging 29 5 739 752 17166628 1:CAS:528:DC%2BD1cXktVKnsrk%3D 10.1016/j.neurobiolaging.2006.11.013 Klegeris A, Pelech S, Giasson BI, Maguire J, Zhang H, McGeer EG, McGeer PL (2008) Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol Aging 29(5):739–752
77. 77. C Roodveldt A Labrador-Garrido E Gonzalez-Rey R Fernandez-Montesinos M Caro CC Lachaud CA Waudby M Delgado CM Dobson D Pozo 2010 Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson’s disease-linked mutants PLoS One 5 10 e13481 10.1371/journal.pone.0013481 21048992 10.1371/journal.pone.0013481 1:CAS:528:DC%2BC3cXhsVSht7%2FN Roodveldt C, Labrador-Garrido A, Gonzalez-Rey E, Fernandez-Montesinos R, Caro M, Lachaud CC, Waudby CA, Delgado M, Dobson CM, Pozo D (2010) Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson’s disease-linked mutants. PLoS One 5(10):e13481. doi: 10.1371/journal.pone.0013481
78. 78. X Su KA Maguire-Zeiss R Giuliano L Prifti K Venkatesh HJ Federoff 2008 Synuclein activates microglia in a model of Parkinson’s disease Neurobiol Aging 29 11 1690 1701 17537546 1:CAS:528:DC%2BD1cXhtFCksLzE 10.1016/j.neurobiolaging.2007.04.006 Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ (2008) Synuclein activates microglia in a model of Parkinson’s disease. Neurobiol Aging 29(11):1690–1701
79. 79. V Sanchez-Guajardo F Febbraro D Kirik M Romero-Ramos 2010 Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson’s disease PLoS One 5 1 e8784 10.1371/journal.pone.0008784 20098715 10.1371/journal.pone.0008784 1:CAS:528:DC%2BC3cXht1entb0%3D Sanchez-Guajardo V, Febbraro F, Kirik D, Romero-Ramos M (2010) Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson’s disease. PLoS One 5(1):e8784. doi: 10.1371/journal.pone.0008784
80. 80. S Theodore S Cao PJ McLean DG Standaert 2008 Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease J Neuropathol Exp Neurol 67 12 1149 1158 10.1097/NEN.0b013e31818e5e99 19018246 1:CAS:528:DC%2BD1MXkt1Gmuw%3D%3D 10.1097/NEN.0b013e31818e5e99 Theodore S, Cao S, McLean PJ, Standaert DG (2008) Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol 67(12):1149–1158. doi: 10.1097/NEN.0b013e31818e5e99
81. 81. S Cao S Theodore DG Standaert 2010 Fcgamma receptors are required for NF-kappaB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson’s disease Mol Neurodegener 5 42 20977765 10.1186/1750-1326-5-42 1:CAS:528:DC%2BC3cXhsVWktr3J Cao S, Theodore S, Standaert DG (2010) Fcgamma receptors are required for NF-kappaB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson’s disease. Mol Neurodegener 5:42
82. 82. L Alvarez-Erviti Y Couch J Richardson JM Cooper MJ Wood 2011 Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line Neurosci Res 69 4 337 342 21255620 1:CAS:528:DC%2BC3MXis1enu7k%3D 10.1016/j.neures.2010.12.020 Alvarez-Erviti L, Couch Y, Richardson J, Cooper JM, Wood MJ (2011) Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line. Neurosci Res 69(4):337–342
83. 83. L Rojanathammanee EJ Murphy CK Combs 2011 Expression of mutant alpha-synuclein modulates microglial phenotype in vitro J Neuroinflammation 8 44 21554732 1:CAS:528:DC%2BC3MXmtlKktrg%3D 10.1186/1742-2094-8-44 Rojanathammanee L, Murphy EJ, Combs CK (2011) Expression of mutant alpha-synuclein modulates microglial phenotype in vitro. J Neuroinflammation 8:44
84. 84. W Zhang T Wang Z Pei DS Miller X Wu ML Block B Wilson Y Zhou JS Hong J Zhang 2005 Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease FASEB J 19 6 533 542 15791003 1:CAS:528:DC%2BD2MXjtFaqsrc%3D 10.1096/fj.04-2751com Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhou Y, Hong JS, Zhang J (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease. FASEB J 19(6):533–542
85. 85. AD Reynolds JG Glanzer I Kadiu M Ricardo-Dukelow A Chaudhuri P Ciborowski R Cerny B Gelman MP Thomas RL Mosley HE Gendelman 2008 Nitrated alpha-synuclein-activated microglial profiling for Parkinson’s disease J Neurochem 104 6 1504 1525 18036154 1:CAS:528:DC%2BD1cXkt1CitbY%3D 10.1111/j.1471-4159.2007.05087.x Reynolds AD, Glanzer JG, Kadiu I, Ricardo-Dukelow M, Chaudhuri A, Ciborowski P, Cerny R, Gelman B, Thomas MP, Mosley RL, Gendelman HE (2008) Nitrated alpha-synuclein-activated microglial profiling for Parkinson’s disease. J Neurochem 104(6):1504–1525
86. 86. JY Park SR Paik I Jou SM Park 2008 Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson’s disease Glia 56 11 1215 1223 10.1002/glia.20691 18449945 10.1002/glia.20691 Park JY, Paik SR, Jou I, Park SM (2008) Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson’s disease. Glia 56(11):1215–1223. doi: 10.1002/glia.20691
87. 87. HJ Lee JE Suk EJ Bae SJ Lee 2008 Clearance and deposition of extracellular alpha-synuclein aggregates in microglia Biochem Biophys Res Commun 372 3 423 428 18492487 1:CAS:528:DC%2BD1cXnt1OrurY%3D 10.1016/j.bbrc.2008.05.045 Lee HJ, Suk JE, Bae EJ, Lee SJ (2008) Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem Biophys Res Commun 372(3):423–428
88. 88. M Hirschfeld Y Ma JH Weis SN Vogel JJ Weis 2000 Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2 J Immunol 165 2 618 622 10878331 1:CAS:528:DC%2BD3cXkvFWisro%3D Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ (2000) Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 165(2):618–622
89. 89. N Stefanova L Fellner M Reindl E Masliah W Poewe GK Wenning 2011 Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons Am J Pathol 179 2 954 963 21801874 1:CAS:528:DC%2BC3MXhtFGjsLzN 10.1016/j.ajpath.2011.04.013 Stefanova N, Fellner L, Reindl M, Masliah E, Poewe W, Wenning GK (2011) Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons. Am J Pathol 179(2):954–963
90. 90. T Arai K Ueda K Ikeda H Akiyama C Haga H Kondo N Kuroki K Niizato S Iritani K Tsuchiya 1999 Argyrophilic glial inclusions in the midbrain of patients with Parkinson’s disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein Neurosci Lett 259 2 83 86 10025563 1:CAS:528:DyaK1cXotVKit7k%3D 10.1016/S0304-3940(98)00890-8 Arai T, Ueda K, Ikeda K, Akiyama H, Haga C, Kondo H, Kuroki N, Niizato K, Iritani S, Tsuchiya K (1999) Argyrophilic glial inclusions in the midbrain of patients with Parkinson’s disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein. Neurosci Lett 259(2):83–86
91. 91. T Yamada PL McGeer EG McGeer 1992 Lewy bodies in Parkinson’s disease are recognized by antibodies to complement proteins Acta Neuropathol 84 1 100 104 1502878 1:STN:280:DyaK38zmslCisQ%3D%3D 10.1007/BF00427222 Yamada T, McGeer PL, McGeer EG (1992) Lewy bodies in Parkinson’s disease are recognized by antibodies to complement proteins. Acta Neuropathol 84(1):100–104
92. 92. T Yamada PL McGeer EG McGeer 1992 Some immunohistochemical features of argyrophilic grain dementia with normal cortical choline acetyltransferase levels but extensive subcortical pathology and markedly reduced dopamine J Geriatr Psychiatry Neurol 5 1 3 13 1315137 1:STN:280:DyaK383jvV2ktQ%3D%3D Yamada T, McGeer PL, McGeer EG (1992) Some immunohistochemical features of argyrophilic grain dementia with normal cortical choline acetyltransferase levels but extensive subcortical pathology and markedly reduced dopamine. J Geriatr Psychiatry Neurol 5(1):3–13
93. 93. H Braak K Tredici Del 2004 Poor and protracted myelination as a contributory factor to neurodegenerative disorders Neurobiol Aging 25 1 19 23 14675725 1:CAS:528:DC%2BD3sXpvVait70%3D 10.1016/j.neurobiolaging.2003.04.001 Braak H, Del Tredici K (2004) Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging 25(1):19–23
94. 94. H Braak K Tredici Del 2009 Neuroanatomy and pathology of sporadic Parkinson’s disease Adv Anat Embryol Cell Biol 201 1 119 19230552 Braak H, Del Tredici K (2009) Neuroanatomy and pathology of sporadic Parkinson’s disease. Adv Anat Embryol Cell Biol 201:1–119
95. 95. A Schrag Y Ben-Shlomo NP Quinn 1999 Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study Lancet 354 9192 1771 1775 10577638 1:STN:280:DC%2BD3c%2FktlGksg%3D%3D 10.1016/S0140-6736(99)04137-9 Schrag A, Ben-Shlomo Y, Quinn NP (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354(9192):1771–1775
96. 96. SS O’Sullivan LA Massey DR Williams L Silveira-Moriyama PA Kempster JL Holton T Revesz AJ Lees 2008 Clinical outcomes of progressive supranuclear palsy and multiple system atrophy Brain 131 Pt 5 1362 1372 18385183 O’Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, Revesz T, Lees AJ (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131(Pt 5):1362–1372
97. 97. A Schrag GK Wenning N Quinn Y Ben-Shlomo 2008 Survival in multiple system atrophy Mov Disord 23 2 294 296 10.1002/mds.21839 18044727 10.1002/mds.21839 Schrag A, Wenning GK, Quinn N, Ben-Shlomo Y (2008) Survival in multiple system atrophy. Mov Disord 23(2):294–296. doi: 10.1002/mds.21839
98. 98. JG Graham DR Oppenheimer 1969 Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy J Neurol Neurosurg Psychiatry 32 1 28 34 5774131 1:STN:280:DyaF1M7jsV2gtQ%3D%3D 10.1136/jnnp.32.1.28 Graham JG, Oppenheimer DR (1969) Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 32(1):28–34
99. 99. GK Wenning C Colosimo F Geser W Poewe 2004 Multiple system atrophy Lancet Neurol 3 2 93 103 14747001 10.1016/S1474-4422(03)00662-8 Wenning GK, Colosimo C, Geser F, Poewe W (2004) Multiple system atrophy. Lancet Neurol 3(2):93–103
100. 100. S Gilman PA Low N Quinn A Albanese Y Ben-Shlomo CJ Fowler H Kaufmann T Klockgether AE Lang PL Lantos I Litvan CJ Mathias E Oliver D Robertson I Schatz GK Wenning 1999 Consensus statement on the diagnosis of multiple system atrophy J Neurol Sci 163 1 94 98 10223419 1:STN:280:DyaK1M3jsl2gsg%3D%3D 10.1016/S0022-510X(98)00304-9 Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163(1):94–98
101. 101. GK Wenning F Tison Y Ben Shlomo SE Daniel NP Quinn 1997 Multiple system atrophy: a review of 203 pathologically proven cases Mov Disord 12 2 133 147 10.1002/mds.870120203 9087971 1:STN:280:DyaK2s3kt12qsw%3D%3D 10.1002/mds.870120203 Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP (1997) Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12(2):133–147. doi: 10.1002/mds.870120203
102. 102. KA Jellinger PL Lantos 2010 Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update Acta Neuropathol 119 6 657 667 10.1007/s00401-010-0672-3 20309568 1:CAS:528:DC%2BC3cXlslWgtL8%3D 10.1007/s00401-010-0672-3 Jellinger KA, Lantos PL (2010) Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol 119(6):657–667. doi: 10.1007/s00401-010-0672-3
103. 103. M Nishie F Mori H Fujiwara M Hasegawa M Yoshimoto T Iwatsubo H Takahashi K Wakabayashi 2004 Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy Acta Neuropathol 107 4 292 298 10.1007/s00401-003-0811-1 14722716 1:CAS:528:DC%2BD2cXitFCnsbs%3D 10.1007/s00401-003-0811-1 Nishie M, Mori F, Fujiwara H, Hasegawa M, Yoshimoto M, Iwatsubo T, Takahashi H, Wakabayashi K (2004) Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Acta Neuropathol 107(4):292–298. doi: 10.1007/s00401-003-0811-1
104. 104. MI Papp PL Lantos 1994 The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology Brain 117 Pt 2 235 243 8186951 10.1093/brain/117.2.235 Papp MI, Lantos PL (1994) The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 117(Pt 2):235–243
105. 105. Ubhi K, Low P, Masliah E (2011) Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci
106. 106. GK Wenning N Stefanova KA Jellinger W Poewe MG Schlossmacher 2008 Multiple system atrophy: a primary oligodendrogliopathy Ann Neurol 64 3 239 246 10.1002/ana.21465 18825660 1:CAS:528:DC%2BD1cXht1yisrzF 10.1002/ana.21465 Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG (2008) Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol 64(3):239–246. doi: 10.1002/ana.21465
107. 107. KA Jellinger K Seppi GK Wenning 2005 Grading of neuropathology in multiple system atrophy: proposal for a novel scale Mov Disord 20 Suppl 12 S29 36 10.1002/mds.20537 16092088 10.1002/mds.20537 Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 20(Suppl 12):S29–36. doi: 10.1002/mds.20537
108. 108. YJ Song GM Halliday JL Holton T Lashley SS O’Sullivan H McCann AJ Lees T Ozawa DR Williams PJ Lockhart TR Revesz 2009 Degeneration in different Parkinsonian syndromes relates to astrocyte type and astrocyte protein expression J Neuropathol Exp Neurol 68 10 1073 1083 10.1097/NEN.0b013e3181b66f1b 19918119 1:CAS:528:DC%2BD1MXhtFyntrfN 10.1097/NEN.0b013e3181b66f1b Song YJ, Halliday GM, Holton JL, Lashley T, O’Sullivan SS, McCann H, Lees AJ, Ozawa T, Williams DR, Lockhart PJ, Revesz TR (2009) Degeneration in different Parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J Neuropathol Exp Neurol 68(10):1073–1083. doi: 10.1097/NEN.0b013e3181b66f1b
109. 109. CW Shults E Rockenstein L Crews A Adame M Mante G Larrea M Hashimoto D Song T Iwatsubo K Tsuboi E Masliah 2005 Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy J Neurosci 25 46 10689 10699 16291942 1:CAS:528:DC%2BD2MXht1KqsbzP 10.1523/JNEUROSCI.3527-05.2005 Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G, Hashimoto M, Song D, Iwatsubo T, Tsuboi K, Masliah E (2005) Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 25(46):10689–10699
110. 110. N Stefanova M Reindl M Neumann C Haass W Poewe PJ Kahle GK Wenning 2005 Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy Am J Pathol 166 3 869 876 15743798 1:CAS:528:DC%2BD2MXivVOmsb0%3D 10.1016/S0002-9440(10)62307-3 Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, Wenning GK (2005) Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol 166(3):869–876
111. 111. K Ishizawa T Komori S Sasaki N Arai T Mizutani T Hirose 2004 Microglial activation parallels system degeneration in multiple system atrophy J Neuropathol Exp Neurol 63 1 43 52 14748560 Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, Hirose T (2004) Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol 63(1):43–52
112. 112. N Stefanova M Reindl M Neumann PJ Kahle W Poewe GK Wenning 2007 Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy Mov Disord 22 15 2196 2203 10.1002/mds.21671 17853477 10.1002/mds.21671 Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, Wenning GK (2007) Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov Disord 22(15):2196–2203. doi: 10.1002/mds.21671
113. 113. T Ozawa K Okuizumi T Ikeuchi K Wakabayashi H Takahashi S Tsuji 2001 Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy Acta Neuropathol 102 2 188 190 11563635 1:CAS:528:DC%2BD3MXlslGksLk%3D Ozawa T, Okuizumi K, Ikeuchi T, Wakabayashi K, Takahashi H, Tsuji S (2001) Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol 102(2):188–190
114. 114. GK Wenning N Quinn M Magalhaes C Mathias SE Daniel 1994 “Minimal change” multiple system atrophy Mov Disord 9 2 161 166 10.1002/mds.870090206 8196676 1:STN:280:DyaK2c3lsV2jsA%3D%3D 10.1002/mds.870090206 Wenning GK, Quinn N, Magalhaes M, Mathias C, Daniel SE (1994) “Minimal change” multiple system atrophy. Mov Disord 9(2):161–166. doi: 10.1002/mds.870090206
115. 115. K Wakabayashi H Takahashi 2006 Cellular pathology in multiple system atrophy Neuropathology 26 4 338 345 16961071 10.1111/j.1440-1789.2006.00713.x Wakabayashi K, Takahashi H (2006) Cellular pathology in multiple system atrophy. Neuropathology 26(4):338–345
116. 116. E Emmanouilidou K Melachroinou T Roumeliotis SD Garbis M Ntzouni LH Margaritis L Stefanis K Vekrellis 2010 Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival J Neurosci 30 20 6838 6851 20484626 1:CAS:528:DC%2BC3cXovVWnurk%3D 10.1523/JNEUROSCI.5699-09.2010 Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, Vekrellis K (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30(20):6838–6851
117. 117. S Nakamura Y Kawamoto S Nakano I Akiguchi 2000 Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy Clin Neuropathol 19 2 51 56 10749284 1:STN:280:DC%2BD3c3htVymtw%3D%3D Nakamura S, Kawamoto Y, Nakano S, Akiguchi I (2000) Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy. Clin Neuropathol 19(2):51–56
118. 118. N Stefanova M Hainzer S Stemberger S Couillard-Despres L Aigner W Poewe GK Wenning 2009 Striatal transplantation for multiple system atrophy—are grafts affected by alpha-synucleinopathy? Exp Neurol 219 1 368 371 19460374 10.1016/j.expneurol.2009.05.016 Stefanova N, Hainzer M, Stemberger S, Couillard-Despres S, Aigner L, Poewe W, Wenning GK (2009) Striatal transplantation for multiple system atrophy—are grafts affected by alpha-synucleinopathy? Exp Neurol 219(1):368–371
119. 119. F Mori K Tanji M Yoshimoto H Takahashi K Wakabayashi 2002 Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment Exp Neurol 176 1 98 104 12093086 1:CAS:528:DC%2BD38XkvFKrsrk%3D 10.1006/exnr.2002.7929 Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K (2002) Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp Neurol 176(1):98–104
120. 120. C Richter-Landsberg M Gorath JQ Trojanowski VM Lee 2000 alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes J Neurosci Res 62 1 9 14 10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U 11002283 1:CAS:528:DC%2BD3cXnsVSgtLY%3D 10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U Richter-Landsberg C, Gorath M, Trojanowski JQ, Lee VM (2000) alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes. J Neurosci Res 62(1):9–14. doi:10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U
121. 121. DW Miller JM Johnson SM Solano ZR Hollingsworth DG Standaert AB Young 2005 Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia J Neural Transm 112 12 1613 1624 10.1007/s00702-005-0378-1 16284907 1:CAS:528:DC%2BD2MXht1Skt7fI 10.1007/s00702-005-0378-1 Miller DW, Johnson JM, Solano SM, Hollingsworth ZR, Standaert DG, Young AB (2005) Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm 112(12):1613–1624. doi: 10.1007/s00702-005-0378-1
122. 122. M Riedel O Goldbaum C Richter-Landsberg 2009 alpha-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress J Mol Neurosci 39 1-2 226 234 10.1007/s12031-009-9190-y 19266322 1:CAS:528:DC%2BD1MXhtFaksbrI 10.1007/s12031-009-9190-y Riedel M, Goldbaum O, Richter-Landsberg C (2009) alpha-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress. J Mol Neurosci 39(1-2):226–234. doi: 10.1007/s12031-009-9190-y
123. 123. E Lindersson D Lundvig C Petersen P Madsen JR Nyengaard P Hojrup T Moos D Otzen WP Gai PC Blumbergs PH Jensen 2005 p25alpha stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies J Biol Chem 280 7 5703 5715 15590652 1:CAS:528:DC%2BD2MXhtlClsb4%3D 10.1074/jbc.M410409200 Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Hojrup P, Moos T, Otzen D, Gai WP, Blumbergs PC, Jensen PH (2005) p25alpha stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem 280(7):5703–5715
124. 124. YJ Song DM Lundvig Y Huang WP Gai PC Blumbergs P Hojrup D Otzen GM Halliday PH Jensen 2007 p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy Am J Pathol 171 4 1291 1303 17823288 1:CAS:528:DC%2BD2sXht1SmtrzP 10.2353/ajpath.2007.070201 Song YJ, Lundvig DM, Huang Y, Gai WP, Blumbergs PC, Hojrup P, Otzen D, Halliday GM, Jensen PH (2007) p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol 171(4):1291–1303
125. 125. CL Kragh LB Lund F Febbraro HD Hansen WP Gai O El-Agnaf C Richter-Landsberg PH Jensen 2009 {alpha}-Synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells J Biol Chem 284 15 10211 10222 19203998 1:CAS:528:DC%2BD1MXjvFKksb4%3D 10.1074/jbc.M809671200 Kragh CL, Lund LB, Febbraro F, Hansen HD, Gai WP, El-Agnaf O, Richter-Landsberg C, Jensen PH (2009) {alpha}-Synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells. J Biol Chem 284(15):10211–10222
126. 126. Miki Y, Mori F, Tanji K, Kakita A, Takahashi H, Wakabayashi K (2011) Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions. Neuropathology. doi: 10.1111/j.1440-1789.2011.01200.x
127. 127. Y Kawaguchi JJ Kovacs A McLaurin JM Vance A Ito TP Yao 2003 The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress Cell 115 6 727 738 14675537 1:CAS:528:DC%2BD3sXhtVWgurfL 10.1016/S0092-8674(03)00939-5 Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115(6):727–738
128. 128. A Iwata BE Riley JA Johnston RR Kopito 2005 HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin J Biol Chem 280 48 40282 40292 16192271 1:CAS:528:DC%2BD2MXht1Gjs7vM 10.1074/jbc.M508786200 Iwata A, Riley BE, Johnston JA, Kopito RR (2005) HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 280(48):40282–40292
129. 129. T Pan S Kondo W Le J Jankovic 2008 The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson’s disease Brain 131 Pt 8 1969 1978 18187492 10.1093/brain/awm318 Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson’s disease. Brain 131(Pt 8):1969–1978
130. 130. N Stefanova L Klimaschewski W Poewe GK Wenning M Reindl 2001 Glial cell death induced by overexpression of alpha-synuclein J Neurosci Res 65 5 432 438 10.1002/jnr.1171 11536327 1:CAS:528:DC%2BD3MXmvFWgs7k%3D 10.1002/jnr.1171 Stefanova N, Klimaschewski L, Poewe W, Wenning GK, Reindl M (2001) Glial cell death induced by overexpression of alpha-synuclein. J Neurosci Res 65(5):432–438. doi: 10.1002/jnr.1171
131. 131. N Stefanova K Schanda L Klimaschewski W Poewe GK Wenning M Reindl 2003 Tumor necrosis factor-alpha-induced cell death in U373 cells overexpressing alpha-synuclein J Neurosci Res 73 3 334 340 10.1002/jnr.10662 12868067 1:CAS:528:DC%2BD3sXmt1Gjsrg%3D 10.1002/jnr.10662 Stefanova N, Schanda K, Klimaschewski L, Poewe W, Wenning GK, Reindl M (2003) Tumor necrosis factor-alpha-induced cell death in U373 cells overexpressing alpha-synuclein. J Neurosci Res 73(3):334–340. doi: 10.1002/jnr.10662
132. 132. K Tsuboi JJ Grzesiak M Bouvet M Hashimoto E Masliah CW Shults 2005 Alpha-synuclein overexpression in oligodendrocytic cells results in impaired adhesion to fibronectin and cell death Mol Cell Neurosci 29 2 259 268 15911350 1:CAS:528:DC%2BD2MXks1Wltbc%3D 10.1016/j.mcn.2005.03.001 Tsuboi K, Grzesiak JJ, Bouvet M, Hashimoto M, Masliah E, Shults CW (2005) Alpha-synuclein overexpression in oligodendrocytic cells results in impaired adhesion to fibronectin and cell death. Mol Cell Neurosci 29(2):259–268
133. 133. S Stemberger W Poewe GK Wenning N Stefanova 2010 Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure Exp Neurol 224 2 459 464 20493840 1:CAS:528:DC%2BC3cXovFCgt70%3D 10.1016/j.expneurol.2010.05.008 Stemberger S, Poewe W, Wenning GK, Stefanova N (2010) Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Exp Neurol 224(2):459–464
134. 134. I Yazawa BI Giasson R Sasaki B Zhang S Joyce K Uryu JQ Trojanowski VM Lee 2005 Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration Neuron 45 6 847 859 15797547 1:CAS:528:DC%2BD2MXjt1Oitb4%3D 10.1016/j.neuron.2005.01.032 Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K, Trojanowski JQ, Lee VM (2005) Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45(6):847–859
135. 135. K Ubhi E Rockenstein M Mante C Inglis A Adame C Patrick K Whitney E Masliah 2010 Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors J Neurosci 30 18 6236 6246 20445049 1:CAS:528:DC%2BC3cXovVWmsLg%3D 10.1523/JNEUROSCI.0567-10.2010 Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, Whitney K, Masliah E (2010) Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci 30(18):6236–6246
136. 136. N Aubin O Curet A Deffois C Carter 1998 Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice J Neurochem 71 4 1635 1642 9751197 1:CAS:528:DyaK1cXmt1Kit7s%3D 10.1046/j.1471-4159.1998.71041635.x Aubin N, Curet O, Deffois A, Carter C (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71(4):1635–1642
137. 137. E Esposito V Matteo Di A Benigno M Pierucci G Crescimanno G Giovanni Di 2007 Non-steroidal anti-inflammatory drugs in Parkinson’s disease Exp Neurol 205 2 295 312 17433296 1:CAS:528:DC%2BD2sXls1aisLw%3D 10.1016/j.expneurol.2007.02.008 Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G (2007) Non-steroidal anti-inflammatory drugs in Parkinson’s disease. Exp Neurol 205(2):295–312
138. 138. M Hirohata K Ono A Morinaga M Yamada 2008 Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro Neuropharmacology 54 3 620 627 18164319 1:CAS:528:DC%2BD1cXhsVSgtLw%3D 10.1016/j.neuropharm.2007.11.010 Hirohata M, Ono K, Morinaga A, Yamada M (2008) Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. Neuropharmacology 54(3):620–627
139. 139. KW Lee W Chen E Junn JY Im H Grosso PK Sonsalla X Feng N Ray JR Fernandez Y Chao E Masliah M Voronkov SP Braithwaite JB Stock MM Mouradian 2011 Enhanced phosphatase activity attenuates alpha-synucleinopathy in a mouse model J Neurosci 31 19 6963 6971 21562258 1:CAS:528:DC%2BC3MXmsVKrtrw%3D 10.1523/JNEUROSCI.6513-10.2011 Lee KW, Chen W, Junn E, Im JY, Grosso H, Sonsalla PK, Feng X, Ray N, Fernandez JR, Chao Y, Masliah E, Voronkov M, Braithwaite SP, Stock JB, Mouradian MM (2011) Enhanced phosphatase activity attenuates alpha-synucleinopathy in a mouse model. J Neurosci 31(19):6963–6971
140. 140. HM Gao PT Kotzbauer K Uryu S Leight JQ Trojanowski VM Lee 2008 Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration J Neurosci 28 30 7687 7698 18650345 1:CAS:528:DC%2BD1cXpt12muro%3D 10.1523/JNEUROSCI.0143-07.2008 Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VM (2008) Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci 28(30):7687–7698
141. 141. HM Gao H Zhou F Zhang BC Wilson W Kam JS Hong 2011 HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration J Neurosci 31 3 1081 1092 21248133 1:CAS:528:DC%2BC3MXhsVemtL4%3D 10.1523/JNEUROSCI.3732-10.2011 Gao HM, Zhou H, Zhang F, Wilson BC, Kam W, Hong JS (2011) HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J Neurosci 31(3):1081–1092
142. 142. T Breidert J Callebert MT Heneka G Landreth JM Launay EC Hirsch 2002 Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson’s disease J Neurochem 82 3 615 624 12153485 1:CAS:528:DC%2BD38Xmt1ejsLY%3D 10.1046/j.1471-4159.2002.00990.x Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC (2002) Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson’s disease. J Neurochem 82(3):615–624
143. 143. T Dehmer MT Heneka M Sastre J Dichgans JB Schulz 2004 Protection by pioglitazone in the MPTP model of Parkinson’s disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation J Neurochem 88 2 494 501 14690537 1:CAS:528:DC%2BD2cXntlWjug%3D%3D 10.1046/j.1471-4159.2003.02210.x Dehmer T, Heneka MT, Sastre M, Dichgans J, Schulz JB (2004) Protection by pioglitazone in the MPTP model of Parkinson’s disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem 88(2):494–501
144. 144. LH Randy B Guoying 2007 Agonism of peroxisome proliferator receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson’s disease Curr Neuropharmacol 5 1 35 46 18615152 10.2174/157015907780077123 Randy LH, Guoying B (2007) Agonism of peroxisome proliferator receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson’s disease. Curr Neuropharmacol 5(1):35–46
145. 145. N Stefanova H Eriksson B Georgievska W Poewe GK Wenning 2010 Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model Mov Disord 25 Suppl. 3 625 Stefanova N, Eriksson H, Georgievska B, Poewe W, Wenning GK (2010) Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Mov Disord 25(suppl 3):625
146. 146. X Wang S Zhu M Drozda W Zhang IG Stavrovskaya E Cattaneo RJ Ferrante BS Kristal RM Friedlander 2003 Minocycline inhibits caspase-independent and-dependent mitochondrial cell death pathways in models of Huntington’s disease Proc Natl Acad Sci U S A 100 18 10483 10487 10.1073/pnas.1832501100 12930891 1:CAS:528:DC%2BD3sXntFynsLw%3D 10.1073/pnas.1832501100 Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM (2003) Minocycline inhibits caspase-independent and-dependent mitochondrial cell death pathways in models of Huntington’s disease. Proc Natl Acad Sci U S A 100(18):10483–10487. doi: 10.1073/pnas.1832501100
147. 147. MJ Casarejos J Menendez RM Solano JA Rodriguez-Navarro J Garcia de Yebenes MA Mena 2006 Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline J Neurochem 97 4 934 946 16573651 1:CAS:528:DC%2BD28XlsVOnsbY%3D 10.1111/j.1471-4159.2006.03777.x Casarejos MJ, Menendez J, Solano RM, Rodriguez-Navarro JA, Garcia de Yebenes J, Mena MA (2006) Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem 97(4):934–946
148. 148. N Stefanova M Mitschnigg I Ghorayeb E Diguet F Geser F Tison W Poewe GK Wenning 2004 Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration J Neurosci Res 78 1 87 91 10.1002/jnr.20233 15372496 1:CAS:528:DC%2BD2cXosV2jsbc%3D 10.1002/jnr.20233 Stefanova N, Mitschnigg M, Ghorayeb I, Diguet E, Geser F, Tison F, Poewe W, Wenning GK (2004) Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration. J Neurosci Res 78(1):87–91. doi: 10.1002/jnr.20233
149. 149. DC Wu V Jackson-Lewis M Vila K Tieu P Teismann C Vadseth DK Choi H Ischiropoulos S Przedborski 2002 Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease J Neurosci 22 5 1763 1771 11880505 1:CAS:528:DC%2BD38XhvValtbo%3D Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22(5):1763–1771
150. 150. LY Kong MK McMillian PM Hudson L Jin JS Hong 1997 Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures J Pharmacol Exp Ther 280 1 61 66 8996182 1:CAS:528:DyaK2sXntVSksg%3D%3D Kong LY, McMillian MK, Hudson PM, Jin L, Hong JS (1997) Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J Pharmacol Exp Ther 280(1):61–66
151. 151. X Lu G Bing T Hagg 2000 Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats Neuroscience 97 2 285 291 10799760 1:CAS:528:DC%2BD3cXivVCqs74%3D 10.1016/S0306-4522(00)00033-6 Lu X, Bing G, Hagg T (2000) Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats. Neuroscience 97(2):285–291
152. 152. JJ Gagne MC Power 2010 Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis Neurology 74 12 995 1002 20308684 1:CAS:528:DC%2BC3cXjs1Ggsbs%3D 10.1212/WNL.0b013e3181d5a4a3 Gagne JJ, Power MC (2010) Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 74(12):995–1002
153. 153. Becker C, Jick SS, Meier CR (2011) NSAID use and risk of Parkinson disease: a population-based case–control study. Eur J Neurol. doi: 10.1111/j.1468-1331.2011.03399.x
154. 154. E Polazzi B Monti 2010 Microglia and neuroprotection: from in vitro studies to therapeutic applications Prog Neurobiol 92 3 293 315 20609379 10.1016/j.pneurobio.2010.06.009 Polazzi E, Monti B (2010) Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog Neurobiol 92(3):293–315
155. 155. A Samii M Etminan MO Wiens S Jafari 2009 NSAID use and the risk of Parkinson’s disease: systematic review and meta-analysis of observational studies Drugs Aging 26 9 769 779 10.2165/11316780-000000000-00000 19728750 1:CAS:528:DC%2BD1MXhsVCkt7%2FM 10.2165/11316780-000000000-00000 Samii A, Etminan M, Wiens MO, Jafari S (2009) NSAID use and the risk of Parkinson’s disease: systematic review and meta-analysis of observational studies. Drugs Aging 26(9):769–779. doi: 10.2165/11316780-000000000-00000
156. 156. R Dodel A Spottke A Gerhard A Reuss S Reinecker N Schimke C Trenkwalder F Sixel-Doring B Herting C Kamm T Gasser M Sawires F Geser M Kollensperger K Seppi M Kloss M Krause C Daniels G Deuschl S Bottger M Naumann A Lipp D Gruber A Kupsch Y Du F Turkheimer DJ Brooks T Klockgether W Poewe G Wenning C Schade-Brittinger WH Oertel K Eggert 2010 Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial) Mov Disord 25 1 97 107 10.1002/mds.22732 20014118 10.1002/mds.22732 Dodel R, Spottke A, Gerhard A, Reuss A, Reinecker S, Schimke N, Trenkwalder C, Sixel-Doring F, Herting B, Kamm C, Gasser T, Sawires M, Geser F, Kollensperger M, Seppi K, Kloss M, Krause M, Daniels C, Deuschl G, Bottger S, Naumann M, Lipp A, Gruber D, Kupsch A, Du Y, Turkheimer F, Brooks DJ, Klockgether T, Poewe W, Wenning G, Schade-Brittinger C, Oertel WH, Eggert K (2010) Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). Mov Disord 25(1):97–107. doi: 10.1002/mds.22732
157. 157. B Racette 2008 A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results Clin Neuropharmacol 31 3 141 150 10.1097/WNF.0b013e3181342f32 10.1097/WNF.0b013e3181342f32 1:CAS:528:DC%2BD1cXmsFymu7c%3D Racette B (2008) A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results. Clin Neuropharmacol 31(3):141–150. doi: 10.1097/WNF.0b013e3181342f32
158. 158. EJ Benner RL Mosley CJ Destache TB Lewis V Jackson-Lewis S Gorantla C Nemachek SR Green S Przedborski HE Gendelman 2004 Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson’s disease Proc Natl Acad Sci U S A 101 25 9435 9440 10.1073/pnas.0400569101 15197276 1:CAS:528:DC%2BD2cXltlKjsLk%3D 10.1073/pnas.0400569101 Benner EJ, Mosley RL, Destache CJ, Lewis TB, Jackson-Lewis V, Gorantla S, Nemachek C, Green SR, Przedborski S, Gendelman HE (2004) Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson’s disease. Proc Natl Acad Sci U S A 101(25):9435–9440. doi: 10.1073/pnas.0400569101
159. 159. AD Reynolds R Banerjee J Liu HE Gendelman RL Mosley 2007 Neuroprotective activities of CD4 + CD25+ regulatory T cells in an animal model of Parkinson’s disease J Leukoc Biol 82 5 1083 1094 17675560 1:CAS:528:DC%2BD2sXht1KqsbzI 10.1189/jlb.0507296 Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL (2007) Neuroprotective activities of CD4 + CD25+ regulatory T cells in an animal model of Parkinson’s disease. J Leukoc Biol 82(5):1083–1094
160. 160. EJ Benner R Banerjee AD Reynolds S Sherman VM Pisarev V Tsiperson C Nemachek P Ciborowski S Przedborski RL Mosley HE Gendelman 2008 Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons PLoS One 3 1 e1376 10.1371/journal.pone.0001376 18167537 10.1371/journal.pone.0001376 1:CAS:528:DC%2BD1cXhtVSnu74%3D Benner EJ, Banerjee R, Reynolds AD, Sherman S, Pisarev VM, Tsiperson V, Nemachek C, Ciborowski P, Przedborski S, Mosley RL, Gendelman HE (2008) Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLoS One 3(1):e1376. doi: 10.1371/journal.pone.0001376
161. 161. E Masliah E Rockenstein A Adame M Alford L Crews M Hashimoto P Seubert M Lee J Goldstein T Chilcote D Games D Schenk 2005 Effects of alpha-synuclein immunization in a mouse model of Parkinson’s disease Neuron 46 6 857 868 15953415 1:CAS:528:DC%2BD2MXlvVWjtLg%3D 10.1016/j.neuron.2005.05.010 Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M, Seubert P, Lee M, Goldstein J, Chilcote T, Games D, Schenk D (2005) Effects of alpha-synuclein immunization in a mouse model of Parkinson’s disease. Neuron 46(6):857–868
162. 162. K Ubhi E Rockenstein M Mante C Patrick A Adame M Thukral C Shults E Masliah 2008 Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy Neuroreport 19 13 1271 1276 10.1097/WNR.0b013e32830b3661 18695506 1:CAS:528:DC%2BD1cXhtVyntbnN 10.1097/WNR.0b013e32830b3661 Ubhi K, Rockenstein E, Mante M, Patrick C, Adame A, Thukral M, Shults C, Masliah E (2008) Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy. Neuroreport 19(13):1271–1276. doi: 10.1097/WNR.0b013e32830b3661
163. 163. K Biju Q Zhou G Li SZ Imam JL Roberts WW Morgan RA Clark S Li 2010 Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson’s disease Mol Ther 18 8 1536 1544 20531393 1:CAS:528:DC%2BC3cXntFSmtLo%3D 10.1038/mt.2010.107 Biju K, Zhou Q, Li G, Imam SZ, Roberts JL, Morgan WW, Clark RA, Li S (2010) Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson’s disease. Mol Ther 18(8):1536–1544
164. 164. WJ Marks Jr RT Bartus J Siffert CS Davis A Lozano N Boulis J Vitek M Stacy D Turner L Verhagen R Bakay R Watts B Guthrie J Jankovic R Simpson M Tagliati R Alterman M Stern G Baltuch PA Starr PS Larson JL Ostrem J Nutt K Kieburtz JH Kordower CW Olanow 2010 Gene delivery of AAV2-neurturin for Parkinson’s disease: a double-blind, randomised, controlled trial Lancet Neurol 9 12 1164 1172 20970382 1:CAS:528:DC%2BC3cXhsVWqsbrP 10.1016/S1474-4422(10)70254-4 Marks WJ Jr, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, Tagliati M, Alterman R, Stern M, Baltuch G, Starr PA, Larson PS, Ostrem JL, Nutt J, Kieburtz K, Kordower JH, Olanow CW (2010) Gene delivery of AAV2-neurturin for Parkinson’s disease: a double-blind, randomised, controlled trial. Lancet Neurol 9(12):1164–1172